SCHEMBL61064

SCHEMBL61064

NC(=O)CCC(N)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL61065 1.00
SCHEMBL887143 1.00
SCHEMBL1509733 0.88 ALOX15 (0.43)
SCHEMBL52133 0.80
SCHEMBL756717 0.80
Ammonia Solution, Strong SCHEMBL28439739 0.78 CYP2D6 (0.61)
SCHEMBL9069778 0.78
SCHEMBL2744870 0.78
Hydrochloric Acid SCHEMBL21820004 0.78 CYP2D6 (0.61)
SCHEMBL285407 0.75 CYP2D6 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 16919 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024105062-A1 METHODS FOR TREATING OR PREVENTING TRANSTHYRETIN-MEDIATED AMYLOIDOSIS NEURIMMUNE AG (CH) 2024-05-23 WO claimed
WO-2024105092-A1 PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING TRANSTHYRETIN-MEDIATED AMYLOIDOSIS NEURIMMUNE AG (CH) 2024-05-23 WO claimed
WO-2024042250-A1 PHARMACEUTICAL FORMULATION AND DOSING REGIMEN FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AL-S PHARMA AG (CH) 2024-02-29 WO claimed
US-20230167109-A1 Aminopiperidine Amides, Derivatives, Compositions, and Uses Related to CXCR4 Modulation UNIV EMORY (US) 2023-06-01 US claimed
CN-115645543-A Maytansinoid derivatives, conjugates thereof, and methods of use 里珍纳龙药品有限公司 2023-01-31 CN claimed
CN-114822688-A Prognostic analysis method based on primary liver cancer gene classification and liver cancer tissue energy metabolism 浙江大学医学院附属第一医院 2022-07-29 CN claimed
US-20220175872-A1 THERMOGENIC COMPOSITIONS AND METHODS OHIO STATE INNOVATION FOUNDATION 2022-06-09 US claimed
WO-2022071436-A1 METHOD FOR MEASURING RNA CAPABLE OF DETECTING BIOLOGICAL AND PHYSIOLOGICAL PROCESSES 国立研究開発法人医薬基盤・健康・栄養研究所 2022-04-07 WO claimed
WO-2021217143-A1 AMINOPIPERIDINE AMIDES, DERIVATIVES, COMPOSITIONS, AND USES RELATED TO CXCR4 MODULATION EMORY UNIVERSITY (US) 2021-10-28 WO claimed
US-20200362006-A1 ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION AMRYT RESEARCH LIMITED (IE) 2020-11-19 US claimed
US-4401659-A ANTI-INFECTIOUS AGENTS AGENCE NATIONAL DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) 1983-08-30 US claimed
EP-0013651-B1 MURAMYL PEPTIDES FIXED ON PEPTIDE POLYMERS AND MEDICAMENTS CONTAINING THEM ANVAR Agence Nationale de Valorisation de la Recherche (FR) 1983-06-15 EP claimed
EP-0018072-B1 SYNTHETIC PEPTIDES HAVING PITUITARY GROWTH HORMONE RELEASING ACTIVITY BECKMAN INSTRUMENTS, INC. (US) 1983-01-26 EP claimed
US-4314936-A BY MEASUREM,ENT OF FLUORESENCE YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 1982-02-09 US claimed
US-4311699-A Aminoacid derivatives of cephalosporin compounds HASKELL THEODORE H 1982-01-19 US claimed
WO-1981003329-A1 OLIGOPEPTIDES WITH SPECIFIC INHIBITING PROPERTIES OF COLLAGEN INDUCED AGGREGATION,PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM CHOAY SA (FR) 1981-11-26 WO claimed
EP-0040149-A1 Oligopeptides with specific inhibiting properties of collagen induced aggregation, process for preparing the same and pharmaceutical compositions containing them CHOAY S.A. (FR) 1981-11-18 EP claimed
EP-0015772-A1 N-(2-((acylaminoacylamino or aminoacylamino)phenyl)-4-hydroxy-5-pyrimidinylcarbonyl)cephalosporin compounds, processes for their production, and compositions containing the same WARNER-LAMBERT COMPANY (US) 1980-09-17 EP claimed
US-4187298-A MOTHPROOFING AGENTS, PICKLING INHIBITORS ABBOTT LABORATORIES (US) 1980-02-05 US claimed
US-3956260-A ANTIINFLAMMATORY CIBA-GEIGY CORPORATION (US) 1976-05-11 US claimed